Nanosuspension Formulation for the Management of Hypertension
(Sprache: Englisch)
Hypertension is one of the primary risk factors for heart disease and stroke, the leading causes of death worldwide. Telmisartan is BCS class II, anti-hypertensive drug.The aim of present work was to develop a Telmisartan nanosuspension for faster onset of...
Leider schon ausverkauft
versandkostenfrei
Buch
61.90 €
30 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Nanosuspension Formulation for the Management of Hypertension “
Klappentext zu „Nanosuspension Formulation for the Management of Hypertension “
Hypertension is one of the primary risk factors for heart disease and stroke, the leading causes of death worldwide. Telmisartan is BCS class II, anti-hypertensive drug.The aim of present work was to develop a Telmisartan nanosuspension for faster onset of action which is essential in hypertension condition. In the present work nanosuspension is prepared by media milling method. Zirconium oxide beads are used as milling media. The optimization was done using 3level3 factor full factorial design.The optimized batch shown particle size is 356 nm,Zeta potential -8.3 and % drug release after 10 min is 64.20%.
Bibliographische Angaben
- Autoren: Vikram M. Pandya , Praful Bharadia , Divyesh Thakkar
- 2013, 152 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 365933829X
- ISBN-13: 9783659338298
Sprache:
Englisch
Kommentar zu "Nanosuspension Formulation for the Management of Hypertension"
0 Gebrauchte Artikel zu „Nanosuspension Formulation for the Management of Hypertension“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Nanosuspension Formulation for the Management of Hypertension".
Kommentar verfassen